安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- People With Severe Diabetes Are Cured in Small Trial of New Drug
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes Listen to this article · 6:
- Diabetes drug may cut migraine days in half with little . . .
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering pressure in the brain are already planning larger trials Future studies
- Stem Cell-Derived Islet Therapies Shown to Reduce the Need . . .
Stem Cell-Based Treatment with Safety Switch Shows Potential for Patients with Type 1 Diabetes Findings demonstrating the early-stage success of genetically modified stem cell-derived islet (SC-islet) replacement therapies for the treatment of type 1 diabetes, leveraging a novel safety feature, were presented as a late-breaking poster
- Diabetes Breakthrough: New Treatment Eliminates Insulin for . . .
A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of participants in a study no longer requiring insulin therapy The treatment was safe and well-tolerated, and further trials are planned to confirm these results
- HIV Drug, Lamivudine, Potentially Effective Against Diabetic . . .
FRIDAY, June 20, 2025 — A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new small-scale study says The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in which fluid builds up in the retina, researchers
- Son’s diabetes diagnosis sent scientist on quest for cure
Now, more than 30 years later, Melton and his colleagues are within sight of a new treatment for Type 1 diabetes that uses stem cells to make healthy insulin-producing cells that can be transplanted into patients Vertex Pharmaceuticals, a biomedical company headquartered in Boston, is running clinical trials on methods pioneered by Melton and
- High-Dose Semaglutide (Up to 16 mg) in People With Type 2 . . .
An extensive clinical trial program as well as real-world evidence has shown semaglutide to be safe in the treatment of type 2 diabetes with additional benefits such as protection from cardiovascular and renal events (13,24–27) In general, the occurrence of gastrointestinal AEs is the main determinant of semaglutide tolerability
|
|
|